Search results for: 'Complex Drug'

This edition of Trend Opportunity Profiles features trend advancements in health, wellness, and nutrition featuring sensors for food products or pharmaceutical drugs, sustainable nutrition, technology-induced healthcare including AI for drug discovery and blockchain for data intelligence, personalized health solutions, online consultations, behavio...

The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applicati...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

In this research service, Frost & Sullivan provides an overview of the Latin American defense market, highlighting growth drivers and restraints, growth opportunities, and notable companies with active contracts or a presence in the region. The study also outlines the most relevant projects and programs as well as representative contracts. Latin A...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

This research service provides revenue forecasts for CROs globally, by phase and market type, R&D spending trends of pharmaceutical and biotechnology companies and pipeline drugs and clinical trial trends by phase and region.

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.